CompletedPHASE1, PHASE2NCT03871972

Umbilical Cord Blood Transfusion in Progeria Syndrome

Studying Hutchinson-Gilford progeria syndrome

Last synced from ClinicalTrials.gov April 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Bundang CHA Hospital
Principal Investigator: Min Young Kim, MD, PhD
CHA University
Intervention: Umbilical Cord Blood Unit(drug)
Enrollment: 2 target
Eligibility: All sexes
Timeline: 2019 – 2020

Study locations (1)

Bundang CHA Medical Center, Seongnam-si, Gyeonggi-do, South Korea

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03871972 on ClinicalTrials.gov

Other trials for Hutchinson-Gilford progeria syndrome

Additional recruiting or active studies for the same condition.

ACTIVE NOT RECRUITINGPHASE2NCT06775041
Study to Determine Optimal Dose and Evaluate Safety, Tolerability, and Pharmacokinetics of Progerinin in Patients With Hutchinson-Gilford Progeria Syndrome (HGPS)
PRG Science & Technology Co., Ltd.

See all trials for Hutchinson-Gilford progeria syndrome →

← Back to all trials